What does Nutranomics, Inc. do?

Nutranomics, Inc. (NNRX) operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

What is NNRX's market cap?

Nutranomics, Inc. (NNRX) has a market capitalization of approximately $816,232, as of August 25, 2026, based on the most recent share price and shares outstanding.

Does NNRX pay a dividend?

No — Nutranomics, Inc. (NNRX) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.

Nutranomics, Inc. (NNRX) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

NNRX

Nutranomics, Inc.

OTC·Drug Manufacturers, Specialty & Generic · Healthcare

$0.00$0.00+0.00%

Market cap$816.23K·Market closed·Aug 25 8:00 PM UTC

Price Chart

$0.00+$0.00 (+0.00%)today

−91.67%CAGR −39.17%

Select date range

FromTo

Apr 16, 2013Aug 27, 2021 → Aug 27, 2026· 5.0 yrsAug 27, 2026

Key Metrics

NNRX does not currently pay a dividend.

EarningsEarnings Tab

EPS (FWD)—

P/E Ratio (FWD)—

EPS Growth (1Y)—

EPS Growth (3Y)—

EPS Growth (5Y)—

Next Earnings Date—

Last Report DateSep 29

Reported vs Estimate−$0.00

Earnings Surprise—

FinancialsFinancials Tab

Revenue$3.08M

Net Income−$8.07M

Net Margin−261.8%

Operating Cash Flow−$3.77M

Capital Expenditures$184.50K

Free Cash Flow−$3.95M

Return on Equity—

Return on Invested Capital−10.6%

Net Debt$23.67M

Value Graph

PRO

See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.

Click below to see what's inside, then upgrade to unlock for NNRX and 80,000+ other tickers.

EPS · Price vs. Fair Value Price Fair

Income Statement Flow

PRO

See exactly how NNRX's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for NNRX and 80,000+ other tickers.

About Nutranomics, Inc.

Nutranomics, Inc. focuses on the research, development, and marketing of health-focused nutritional products. Their extensive catalog features nearly 500 distinct dietary supplements, encompassing formulations of vitamins, minerals, herbal remedies, and probiotics. Beyond its product offerings, the company provides innovative services, such as its Nutritional Blood Analysis—a diagnostic tool enabling customers to observe their blood cells live on a video monitor—and the patented Assimilation Enhancing System, which is engineered to optimize nutrient absorption. Additionally, Nutranomics…

CEO: Jonathan Bishop
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Exchange: OTC
Employees: 1
Website: www.nutranomics.com

Peers

Peers Tab

FLHLF

Filament Health Corp.

West Island Brands Inc.

Cap

$60.1K

Latest News

News Tab

No recent news available.

Frequently Asked Questions About NNRX

What does Nutranomics, Inc. do?: Nutranomics, Inc. (NNRX) operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.
What is NNRX's market cap?: Nutranomics, Inc. (NNRX) has a market capitalization of approximately $816,232, as of August 25, 2026, based on the most recent share price and shares outstanding.
Does NNRX pay a dividend?: No — Nutranomics, Inc. (NNRX) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.
Is NNRX profitable?: Nutranomics, Inc. (NNRX) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.